Impact of exacerbations of cystic fibrosis on muscle strength

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Burtin, Chris ^a,b   Van Remoortel, Hans ^a,b   Vrijsen, Bart ^a,b   Langer, Daniel ^a,b   Colpaert, Kristine ^b   Gosselink, Rik ^a,b   Decramer, Marc ^b   Dupont, Lieven ^b   Troosters, Thierry ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cystic fibrosis; Exacerbation; Hospitalization; Magnetic stimulation; Muscle function; Physical activity; Quadriceps strength

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FEMORAL NERVE; HOSPITALIZATION; HUMAN; MALE; MUSCLE STRENGTH; NERVE STIMULATION; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; QUADRICEPS FEMORIS MUSCLE; CONTROLLED CLINICAL TRIAL; EXERCISE TOLERANCE; MOTOR ACTIVITY; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE;

ADULT; CYSTIC FIBROSIS; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL;

EID: 84876290570     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-46     Document Type: Article

References (28)

1. Elkin SL, Williams L, Moore M: Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis. Clin Sci (Lond). 2000, 99: 309-314. 10.1042/CS20000020.
2. Pinet C, Cassart M, Scillia P: Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir Crit Care Med. 2003, 168: 989-994. 10.1164/rccm.200303-398OC.
3. Troosters T, Langer D, Vrijsen B: Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J. 2009, 33: 99-106. 10.1183/09031936.00091607.
4. Fogarty AW, Britton J, Clayton A: Are measures of body habitus associated with mortality in cystic fibrosis?. Chest. 2012, 142: 712-717. 10.1378/chest.11-2124.
5. Nixon PA, Orenstein DM, Kelsey SF: The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med. 1992, 327: 1785-1788. 10.1056/NEJM199212173272504.
6. Pianosi P, Leblanc J, Almudevar A: Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax. 2005, 60: 50-54. 10.1136/thx.2003.008102.
7. Britto MT, Kotagal UR, Hornung RW: Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest. 2002, 121: 64-72. 10.1378/chest.121.1.64.
8. de Boer K, Vandemheen KL, Tullis E: Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011, 66: 680-685. 10.1136/thx.2011.161117.
9. Sanders DB, Bittner RC, Rosenfeld M: Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011, 46: 393-400. 10.1002/ppul.21374.
10. Bell SC, Bowerman AM, Nixon LE: Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. Eur J Clin Invest. 2000, 30: 553-559. 10.1046/j.1365-2362.2000.00667.x.
11. Ionescu AA, Nixon LS, Shale DJ: Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis. J Cyst Fibros. 2004, 3: 253-258. 10.1016/j.jcf.2004.07.003.
12. Wieboldt J, Atallah L, Kelly JL: Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis. J Cyst Fibros. 2012, 11: 209-215. 10.1016/j.jcf.2011.12.001.
13. Spruit MA, Gosselink R, Troosters T: Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003, 58: 752-756. 10.1136/thorax.58.9.752.
14. Horsley AR, Davies JC, Gray RD: Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax. 2013, 10.1136/thoraxjnl-2012-202538. [Epub ahead of print]
15. Polkey MI, Kyroussis D, Hamnegard CH: Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve. 1996, 19: 549-555. 10.1002/(SICI)1097-4598(199605)19:5<549::AID-MUS1>3.0.CO;2-B.
16. Fuchs HJ, Borowitz DS, Christiansen DH: Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994, 331: 637-642. 10.1056/NEJM199409083311003.
17. US Department of Health and Human Services: Physical activity and health: a report of the surgeon general. 1996.
18. Dwyer TJ, Alison JA, McKeough ZJ: Evaluation of the SenseWear activity monitor during exercise in cystic fibrosis and in health. Respir Med. 2009, 103: 1511-1517. 10.1016/j.rmed.2009.04.013.
19. Miller MR, Hankinson J, Brusasco V: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.
20. Troosters T, Gosselink R, Decramer M: Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999, 14: 270-274.
21. Bilton D, Canny G, Conway S: Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011, 10 (Suppl 2): S79-S81.
22. Mador MJ, Bozkanat E, Kufel TJ: Quadriceps fatigue after cycle exercise in patients with COPD compared with healthy control subjects. Chest. 2003, 123: 1104-1111. 10.1378/chest.123.4.1104.
23. Saey D, Debigare R, LeBlanc P: Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003, 168: 425-430. 10.1164/rccm.200208-856OC.
24. Kufel TJ, Pineda LA, Mador MJ: Comparison of potentiated and unpotentiated twitches as an index of muscle fatigue. Muscle Nerve. 2002, 25: 438-444. 10.1002/mus.10047.
25. Barry PJ, Waterhouse DF, Reilly CM: Androgens, exercise capacity, and muscle function in cystic fibrosis. Chest. 2008, 134: 1258-1264. 10.1378/chest.08-1091.
26. Selvadurai HC, Blimkie CJ, Meyers N: Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol. 2002, 33: 194-200. 10.1002/ppul.10015.
27. Vivodtzev I, Debigare R, Gagnon P: Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest. 2012, 141: 716-725. 10.1378/chest.11-0839.
28. Vivodtzev I, Decorte N, Wuyam B: Benefits of neuromuscular electrical stimulation prior to endurance training in patients with cystic fibrosis and severe pulmonary dysfunction. Chest. 2012, 10.1378/chest.12-0584.